Heart failure (HF) is a clinical syndrome with high morbidity and mortality, and its prevalence
is rapidly increasing. Galectin-3 (Gal-3) is an important factor in the pathophysiology of HF …

Despite the advances in treatment options, cardiovascular disease (CVDs) remains the
leading cause of death over the world. Chronic inflammatory response and irreversible …

Despite all the important advances in its diagnosis and treatment, acute myocardial
infarction (AMI) is still one of the most prominent causes of morbidity and mortality …

Myocarditis is an inflammatory heart disease induced by infectious and non-infectious
causes frequently triggering immune-mediated pathologic mechanisms leading to …

Objective Findings regarding the prognostic value of soluble suppression of tumorigenecity-
2 (sST2) in patients with coronary artery disease (CAD) remain inconsistent. Therefore, we …

Cardiovascular disease is most frequently caused by the development and progression of
atherosclerosis. When coronary arteries are afflicted, and the stenoses caused by …

Aims: Soluble suppression of tumorigenicity 2 (sST2) was validated to independently predict
prognosis for heart failure (HF) and ST-segment elevation myocardial infarction (STEMI). In …

We investigated whether there were associations between coronary artery disease (CAD)
and soluble suppression of tumorigenicity (sST2) and galectin-3 levels at the time of …

Galectin-3 is the most studied member of the Galectin family, with a large range of mediation
in biological activities such as cell growth, proliferation, apoptosis, differentiation, cell …

Background: Galectin-3 (Gal-3) is a biomarker involved in a wide range of diseases
including cardiac remodeling following acute myocardial infarction (AMI). Identification of …